Pharvaris NV (PHVS)
24.68
+0.37
(+1.52%)
USD |
NASDAQ |
May 01, 16:00
24.68
0.00 (0.00%)
After-Hours: 20:00
Pharvaris Cash from Operations (TTM): -100.74M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -100.74M |
| September 30, 2023 | -99.12M |
| June 30, 2023 | -87.02M |
| March 31, 2023 | -77.84M |
| December 31, 2022 | -70.83M |
| September 30, 2022 | -62.02M |
| June 30, 2022 | -59.81M |
| Date | Value |
|---|---|
| March 31, 2022 | -60.54M |
| December 31, 2021 | -52.77M |
| September 30, 2021 | -47.68M |
| June 30, 2021 | -44.57M |
| March 31, 2021 | -34.28M |
| December 31, 2020 | -24.55M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-100.74M
Minimum
Dec 2023
-24.55M
Maximum
Dec 2020
-63.21M
Average
-60.54M
Median
Mar 2022
Cash from Operations (TTM) Benchmarks
| uniQure NV | -145.93M |
| ProQR Therapeutics NV | 23.33M |
| Merus NV | -142.21M |
| argenx SE | -- |
| Pharming Group | -17.30M |